Ginkgo Bioworks Holdings (DNA) Operating Expenses (2020 - 2025)
Ginkgo Bioworks Holdings filings provide 6 years of Operating Expenses readings, the most recent being $104.1 million for Q4 2025.
- On a quarterly basis, Operating Expenses fell 29.37% to $104.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $485.4 million, a 38.3% decrease, with the full-year FY2025 number at $485.4 million, down 38.3% from a year prior.
- Operating Expenses hit $104.1 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $128.9 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $1.8 billion in Q4 2021 to a low of $101.2 million in Q1 2021.
- Median Operating Expenses over the past 5 years was $214.4 million (2023), compared with a mean of $360.9 million.
- Biggest five-year swings in Operating Expenses: surged 1984.49% in 2021 and later plummeted 82.05% in 2022.
- Ginkgo Bioworks Holdings' Operating Expenses stood at $1.8 billion in 2021, then plummeted by 82.05% to $329.1 million in 2022, then plummeted by 35.33% to $212.9 million in 2023, then tumbled by 30.73% to $147.5 million in 2024, then dropped by 29.37% to $104.1 million in 2025.
- The last three reported values for Operating Expenses were $104.1 million (Q4 2025), $128.9 million (Q3 2025), and $115.1 million (Q2 2025) per Business Quant data.